Published in Curr Opin Biotechnol on February 01, 2005
Targeting quantum dots to surface proteins in living cells with biotin ligase. Proc Natl Acad Sci U S A (2005) 4.15
Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev (2008) 3.18
Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. J Am Chem Soc (2008) 2.79
microPET-based biodistribution of quantum dots in living mice. J Nucl Med (2007) 2.76
Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small (2009) 2.59
Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. Chem Soc Rev (2010) 2.08
Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials (2005) 1.96
Molecular imaging with nanoparticles: giant roles for dwarf actors. Histochem Cell Biol (2008) 1.73
Biocompatible luminescent silicon quantum dots for imaging of cancer cells. ACS Nano (2008) 1.71
Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Curr Drug Discov Technol (2009) 1.60
Development of aliphatic biodegradable photoluminescent polymers. Proc Natl Acad Sci U S A (2009) 1.54
Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond) (2010) 1.51
Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol Sci (2007) 1.48
Nano-flares for mRNA regulation and detection. ACS Nano (2009) 1.41
Membrane lateral diffusion and capture of CFTR within transient confinement zones. Biophys J (2006) 1.36
Quantum dots - characterization, preparation and usage in biological systems. Int J Mol Sci (2009) 1.33
Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano (2010) 1.31
Oxidative quenching and degradation of polymer-encapsulated quantum dots: new insights into the long-term fate and toxicity of nanocrystals in vivo. J Am Chem Soc (2008) 1.31
Nanotechnology applications in surgical oncology. Annu Rev Med (2010) 1.31
Multiplex detection of protease activity with quantum dot nanosensors prepared by intein-mediated specific bioconjugation. Anal Chem (2008) 1.28
Quantum dot-based HIV capture and imaging in a microfluidic channel. Biosens Bioelectron (2009) 1.27
Minimizing the hydrodynamic size of quantum dots with multifunctional multidentate polymer ligands. J Am Chem Soc (2008) 1.26
Inorganic nanoparticle-based contrast agents for molecular imaging. Trends Mol Med (2010) 1.21
Multifunctional Quantum Dots for Personalized Medicine. Nano Today (2009) 1.19
Quantitative multicolor compositional imaging resolves molecular domains in cell-matrix adhesions. PLoS One (2008) 1.19
Semiconductor quantum dots for bioimaging and biodiagnostic applications. Annu Rev Anal Chem (Palo Alto Calif) (2013) 1.18
Bandgap-like strong fluorescence in functionalized carbon nanoparticles. Angew Chem Int Ed Engl (2010) 1.18
Quantum dot enabled molecular sensing and diagnostics. Theranostics (2012) 1.18
In vivo assembly of nanoparticle components to improve targeted cancer imaging. Proc Natl Acad Sci U S A (2010) 1.15
Modeling particle shape-dependent dynamics in nanomedicine. J Nanosci Nanotechnol (2011) 1.14
Metallic Nanostructures as Localized Plasmon Resonance Enhanced Scattering Probes for Multiplex Dark Field Targeted Imaging of Cancer Cells. J Phys Chem C Nanomater Interfaces (2009) 1.12
Clinical potential of quantum dots. J Biomed Biotechnol (2007) 1.12
HaloTag protein-mediated specific labeling of living cells with quantum dots. Biochem Biophys Res Commun (2008) 1.10
Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging. Nano Lett (2013) 1.09
Quantum dots for molecular pathology: their time has arrived. J Mol Diagn (2007) 1.08
Surface engineering of quantum dots for in vivo vascular imaging. Bioconjug Chem (2007) 1.07
Small solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapy. Clin Pharmacol Ther (2009) 1.05
Impact of nanotechnology in cancer: emphasis on nanochemoprevention. Int J Nanomedicine (2012) 1.05
Phosphorescent nanoscale coordination polymers as contrast agents for optical imaging. Angew Chem Int Ed Engl (2011) 1.04
Nanoinformatics: a new area of research in nanomedicine. Int J Nanomedicine (2012) 1.03
The shape of things to come: importance of design in nanotechnology for drug delivery. Ther Deliv (2012) 1.03
Exploring natural silk protein sericin for regenerative medicine: an injectable, photoluminescent, cell-adhesive 3D hydrogel. Sci Rep (2014) 1.03
Quantum dot-based theranostics. Nanoscale (2009) 1.03
Upconversion nanoparticles: synthesis, surface modification and biological applications. Nanomedicine (2011) 1.03
Design and development of molecular imaging probes. Curr Top Med Chem (2010) 1.02
Quantitative determination of skin penetration of PEG-coated CdSe quantum dots in dermabraded but not intact SKH-1 hairless mouse skin. Toxicol Sci (2009) 1.02
Phage display evolution of a peptide substrate for yeast biotin ligase and application to two-color quantum dot labeling of cell surface proteins. J Am Chem Soc (2007) 1.01
Singlet oxygen generation from water-soluble quantum dot-organic dye nanocomposites. J Am Chem Soc (2006) 1.00
Multiplexed detection and characterization of rare tumor cells in Hodgkin's lymphoma with multicolor quantum dots. Anal Chem (2010) 0.99
Preparation and characterization of highly fluorescent, glutathione-coated near infrared quantum dots for in vivo fluorescence imaging. Int J Mol Sci (2008) 0.96
High resolution tumor targeting in living mice by means of multispectral optoacoustic tomography. EJNMMI Res (2012) 0.95
Single-molecule fluorescence in situ hybridization: quantitative imaging of single RNA molecules. BMB Rep (2013) 0.94
In vivo toxicity studies of europium hydroxide nanorods in mice. Toxicol Appl Pharmacol (2009) 0.94
CTC enumeration and characterization: moving toward personalized medicine. Ann Transl Med (2014) 0.94
Visualizing human prostate cancer cells in mouse skeleton using bioconjugated near-infrared fluorescent quantum dots. Urology (2009) 0.93
Progress in circulating tumor cell capture and analysis: implications for cancer management. Expert Rev Mol Diagn (2012) 0.92
Live cell surface labeling with fluorescent Ag nanocluster conjugates. Photochem Photobiol (2008) 0.92
Photoacoustic Imaging for Cancer Detection and Staging. Curr Mol Imaging (2013) 0.91
Synthesis and Cytotoxicity of Y(2)O(3) Nanoparticles of Various Morphologies. Nanoscale Res Lett (2009) 0.91
Insight into factors affecting the presence, degree, and temporal stability of fluorescence intensification on ZnO nanorod ends. Nanoscale (2015) 0.91
Synthesis, Surface Studies, Composition and Structural Characterization of CdSe, Core/Shell, and Biologically Active Nanocrystals. Surf Sci Rep (2007) 0.91
Nanoparticles for imaging and treating brain cancer. Nanomedicine (Lond) (2013) 0.90
Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment. Trends Biotechnol (2009) 0.90
Quantum dot nanobarcodes: epitaxial assembly of nanoparticle-polymer complexes in homogeneous solution. J Am Chem Soc (2008) 0.90
Bioconjugated nanoparticle detection of respiratory syncytial virus infection. Int J Nanomedicine (2007) 0.89
A Quantum Dot-Immunofluorescent Labeling Method to Investigate the Interactions between a Crinivirus and Its Whitefly Vector. Front Microbiol (2013) 0.89
A facile method for immunofluorescence microscopy of highly autofluorescent human retinal sections using nanoparticles with large Stokes shifts. J Neurosci Methods (2010) 0.89
Quantum dots: an insight and perspective of their biological interaction and how this relates to their relevance for clinical use. Theranostics (2012) 0.89
Quantum dots as new-generation fluorochromes for FISH: an appraisal. Chromosome Res (2009) 0.89
Cellular internalization of quantum dots noncovalently conjugated with arginine-rich cell-penetrating peptides. J Nanosci Nanotechnol (2010) 0.89
Multi-functional self-fluorescent unimolecular micelles for tumor-targeted drug delivery and bioimaging. Biomaterials (2015) 0.89
Improved QD-BRET conjugates for detection and imaging. Biochem Biophys Res Commun (2008) 0.88
Review on photoacoustic imaging of the brain using nanoprobes. Neurophotonics (2016) 0.88
Utilization of micelles formed from poly(ethylene glycol)-block-poly(epsilon-caprolactone) block copolymers as nanocarriers to enable hydrophobic red two-photon absorbing emitters for cells imaging. J Biomed Mater Res A (2010) 0.88
Advanced targeted nanomedicine. J Biotechnol (2015) 0.87
Impacts of quantum dots in molecular detection and bioimaging of cancer. Bioimpacts (2014) 0.87
Proton-Resistant Quantum Dots: Stability in Gastrointestinal Fluids and Implications for Oral Delivery of Nanoparticle Agents. Nano Res (2009) 0.87
Development of copper based drugs, radiopharmaceuticals and medical materials. Biometals (2012) 0.87
Nanoparticles for Improving Cancer Diagnosis. Mater Sci Eng R Rep (2013) 0.87
Cell-penetrating peptide-functionalized quantum dots for intracellular delivery. J Nanosci Nanotechnol (2010) 0.87
Immobilization of lactobionic acid on the surface of cadmium sulfide nanoparticles and their interaction with hepatocytes. J Mater Sci Mater Med (2009) 0.86
Generation of a library of non-toxic quantum dots for cellular imaging and siRNA delivery. Adv Mater (2012) 0.86
The Invasion and Reproductive Toxicity of QDs-Transferrin Bioconjugates on Preantral Follicle in vitro. Theranostics (2012) 0.85
Extremely high brightness from polymer-encapsulated quantum dots for two-photon cellular and deep-tissue imaging. Sci Rep (2015) 0.85
Pyrenebutyrate Leads to Cellular Binding, Not Intracellular Delivery, of Polyarginine-Quantum Dots. J Phys Chem Lett (2010) 0.84
Biocompatible polysiloxane-containing diblock copolymer PEO-b-PgammaMPS for coating magnetic nanoparticles. ACS Appl Mater Interfaces (2009) 0.84
2,1,3-Benzothiadiazole (BTD)-moiety-containing red emitter conjugated amphiphilic poly(ethylene glycol)-block-poly(epsilon-caprolactone) copolymers for bioimaging. J Mater Chem (2010) 0.84
Emerging applications of conjugated polymers in molecular imaging. Phys Chem Chem Phys (2013) 0.84
Direct Characterization of Polymer Encapsulated CdSe/CdS/ZnS Quantum Dots. Surf Sci (2016) 0.83
Brightness-equalized quantum dots. Nat Commun (2015) 0.83
Quantum dot fluorescence quenching pathways with Cr(III) complexes. photosensitized NO production from trans-Cr(cyclam)(ONO)2+. J Am Chem Soc (2007) 0.83
Subacute toxicity of cadmium on hepatocytes and nephrocytes in the rat could be considered as a green biosynthesis of nanoparticles. Int J Nanomedicine (2013) 0.81
Imaging GABAc receptors with ligand-conjugated quantum dots. J Biomed Biotechnol (2007) 0.81
Quantum dot loaded immunomicelles for tumor imaging. BMC Med Imaging (2010) 0.81
Exponential growth of publications on carbon nanodots by Chinese authors. J Thorac Dis (2015) 0.81
Multiplexed modular genetic targeting of quantum dots. ACS Nano (2014) 0.81
Progress on the diagnosis and evaluation of brain tumors. Cancer Imaging (2013) 0.81
Inorganic phosphate nanorods are a novel fluorescent label in cell biology. J Nanobiotechnology (2006) 0.80
Quantum dot mediated imaging of atherosclerosis. Nanotechnology (2009) 0.80
Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An Overview. Stem Cells Int (2015) 0.80
In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol (2004) 17.47
The genomic complexity of primary human prostate cancer. Nature (2011) 14.06
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol (2007) 7.33
Tracking the clonal origin of lethal prostate cancer. J Clin Invest (2013) 5.79
Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res (2008) 5.67
Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol (2002) 4.93
mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A (2005) 4.66
Nanotechnology applications in cancer. Annu Rev Biomed Eng (2007) 3.88
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell (2003) 3.66
In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. Nat Nanotechnol (2009) 3.21
Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev (2008) 3.18
Formalin disinfection of biopsy needle minimizes the risk of sepsis following prostate biopsy. J Urol (2013) 2.81
Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. J Am Chem Soc (2008) 2.79
Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res (2008) 2.67
XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology (2010) 2.55
Bioimaging: second window for in vivo imaging. Nat Nanotechnol (2009) 2.48
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat Protoc (2007) 2.45
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther (2006) 2.38
Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res (2004) 2.31
A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano (2010) 2.27
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine (2008) 2.20
Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate (2005) 2.19
Self-assembled nanoparticle probes for recognition and detection of biomolecules. J Am Chem Soc (2002) 2.18
Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin (2008) 2.15
North American white mitochondrial haplogroups in prostate and renal cancer. J Urol (2006) 2.13
Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat Genet (2005) 2.08
Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res (2006) 2.05
Alloyed semiconductor quantum dots: tuning the optical properties without changing the particle size. J Am Chem Soc (2003) 2.00
Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. J Am Chem Soc (2007) 1.98
Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. J Am Chem Soc (2007) 1.95
Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol (2006) 1.94
Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small (2009) 1.93
Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encoding. J Biomed Opt (2002) 1.92
Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells. Nucleic Acids Res (2004) 1.89
A systematic examination of surface coatings on the optical and chemical properties of semiconductor quantum dots. Phys Chem Chem Phys (2006) 1.88
Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin Cancer Res (2009) 1.86
Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem (2006) 1.83
Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells. Clin Cancer Res (2003) 1.82
Using solution-phase nanoparticles, surface-confined nanoparticle arrays and single nanoparticles as biological sensing platforms. J Fluoresc (2004) 1.73
Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer. Clin Cancer Res (2007) 1.71
Counting single native biomolecules and intact viruses with color-coded nanoparticles. Anal Chem (2006) 1.64
Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Res (2008) 1.64
Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene (2005) 1.64
Tuning the optical and electronic properties of colloidal nanocrystals by lattice strain. Nat Nanotechnol (2008) 1.63
Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev Mol Diagn (2006) 1.63
Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. Cancer Res (2002) 1.62
Spectroscopic tags using dye-embedded nanoparticles and surface-enhanced Raman scattering. Anal Chem (2003) 1.61
Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Curr Drug Discov Technol (2009) 1.60
Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect Prev (2004) 1.60
The tuberous sclerosis complex and its highly variable manifestations. J Urol (2003) 1.59
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal (2007) 1.58
Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. J Biol Chem (2005) 1.56
Epididymal sparing bilateral simple orchiectomy with epididymoplasty: preservation of esthetics and body image. J Urol (2005) 1.54
Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells. Eur Urol (2009) 1.54
Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis. Cancer Res (2008) 1.53
Molecular classification of renal tumors by gene expression profiling. J Mol Diagn (2005) 1.52
Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells. Mol Cancer (2010) 1.51
Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond) (2010) 1.51
Real-time detection of gene expression in cancer cells using molecular beacon imaging: new strategies for cancer research. Cancer Res (2005) 1.49
Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer. Cancer (2008) 1.48
Hand-held spectroscopic device for in vivo and intraoperative tumor detection: contrast enhancement, detection sensitivity, and tissue penetration. Anal Chem (2010) 1.47
Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. Gastroenterology (2009) 1.47
Semiconductor nanocrystals: structure, properties, and band gap engineering. Acc Chem Res (2010) 1.46
KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line. Int J Cancer (2006) 1.44
Posterior lumbar vein off the retrohepatic inferior vena cava: a novel anatomical variant with surgical implications. J Urol (2011) 1.43
Impact of laparoscopic inguinal hernia repair mesh on open radical retropubic prostatectomy. Urology (2010) 1.42
Quantum dot nanocrystals for in vivo molecular and cellular imaging. Photochem Photobiol (2004) 1.36
Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles. Cancer Res (2011) 1.36
Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis. Clin Cancer Res (2006) 1.34
Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging. Nanomedicine (Lond) (2006) 1.32
Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano (2010) 1.31
Oxidative quenching and degradation of polymer-encapsulated quantum dots: new insights into the long-term fate and toxicity of nanocrystals in vivo. J Am Chem Soc (2008) 1.31
Nanotechnology applications in surgical oncology. Annu Rev Med (2010) 1.31
Intraoperative near-infrared imaging of surgical wounds after tumor resections can detect residual disease. Clin Cancer Res (2012) 1.30
KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia. J Biol Chem (2006) 1.30
HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. ACS Nano (2009) 1.29
Quantification of the heterogeneity in breast cancer cell lines using whole-cell impedance spectroscopy. Clin Cancer Res (2007) 1.29
HIF at the crossroads between ischemia and carcinogenesis. J Cell Physiol (2004) 1.28
Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. ACS Nano (2013) 1.28
Engineering luminescent quantum dots for in vivo molecular and cellular imaging. Ann Biomed Eng (2006) 1.26
Minimizing the hydrodynamic size of quantum dots with multifunctional multidentate polymer ligands. J Am Chem Soc (2008) 1.26
Mesoporous silica beads embedded with semiconductor quantum dots and iron oxide nanocrystals: dual-function microcarriers for optical encoding and magnetic separation. Anal Chem (2006) 1.25
Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PgammaMPS copolymer coating. Biomaterials (2010) 1.25
Next-generation quantum dots. Nat Biotechnol (2009) 1.25
Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy. Am J Pathol (2011) 1.24
Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles. Theranostics (2012) 1.24
Loss of HOXC6 expression induces apoptosis in prostate cancer cells. Oncogene (2005) 1.23